Instruction for use: Serocryptin

Dosage form: tablets

Active substance: Amantadine*

ATX

N04BC01 Bromocriptine

Pharmacological group:

Dopaminomimetics

The nosological classification (ICD-10)

E22.0 Acromegaly and pituitary gigantism: Pituitary gigantism; Acromegaly; Dysfunction of growth hormone secretion

E22.1 Hyperprolactinaemia: Hyperprolactinemia medication; Hyperprolactinaemia with infertility; Hyperprolactinemia in men; Hyperproduction of prolactin; Idiopathic hyperprolactinemia; Chiari-Frommel Syndrome; Forbes-Albright Syndrome; Tumor galactorrhea; Argonsa del Castillo Syndrome; Forbes-Albright Syndrome

E25 Adrenogenital disorders: Macrogenitomy in boys; Adrenogenital syndrome; Decreased function of the sex glands; Congenital dysfunction of the adrenal cortex; Apera-Halle Syndrome; Crook-Apera-Halle Syndrome

E29 Dysfunction of testicles: Hypofunction of gonads in men; Androgenic dysfunction; Dysfunction of the sex glands; Dysfunction of gonads in men; Underdevelopment of the genitals in men; Primary hypogonadism in men

N91 Absence of menstruation, meager and rare menstruation: Amenorrhea; Amenorrhea hypogonadotropic; Amenorrhea is prolactin-dependent; Oligomenorrhoea; Shortening of the secretory phase of the menstrual cycle; Menstrual disorders; Menstruation disorders; Prolactin-dependent amenorrhea without galactorrhea

N94.3 Premenstrual tension syndrome: Pronounced premenstrual syndrome; Menstrual psychosomatic disorder; Menstrual syndrome; Premenstrual tension; Premenstrual status; Premenstrual period; Premenstrual syndrome; Menstruation syndrome

O92.6 Galactorrhea: Chiari-Frommel Syndrome; Idiopathic galactorrhea

Composition and release form

1 tablet contains bromocriptine mesylate 2.87 mg, equivalent to 2.5 mg bromocriptine; In the package of 30 pcs.

Pharmachologic effect

Mode of action - hypoprolactinemic, dopaminergic.

Reduces the level of growth hormone in the blood with increased concentration of its and / or prolactin.

Indications fot the Serocryptin

Galactorrhea in combination with or without amenorrhea it: postpartum (Chiari-Frommelya syndrome), idiopathic (Argonsa del Castillo syndrome), tumor (Forbes-Albright syndrome), drug-induced (psychotropic, contraceptives) prolaktinzavisimaya amenorrhea without galactorrhea, clinical conditions associated with menstrual disorders (premenstrual syndrome, short luteal phase) prolaktinzavisimy male hypogonadism, acromegaly.

Contraindications

Pregnancy.

Side effects

Dry mouth, nausea, vomiting, dizziness, agitation, dizziness, cramps in the legs, psoriasis, vascular spasm, decrease blood pressure, bleeding in the gastrointestinal tract (for the treatment of acromegaly).

Interaction

It should be used with caution in combination with antihypertensive and psychoactive drugs.

Dosing and Administration

Inside, with food. For 0.5-2 tab. 2-3 times a day for 2 weeks or more (up to 2-3 months); With acromegaly begin with 1 tab. Per day and gradually for 1-2 weeks increase the dose to 4-8 tablets. Per day in 4 divided doses.

Storage conditions of the drug Serocryptin

At a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life of the drug Serocryptin

2 years.

Do not use after the expiry date printed on the package.